Method: A total of 149 patients were divided into two groups according to time of nasal packing removal. Nasal packings were removed 24 (group 1) and 48 (group 2) hours after septoplasty. Patients with complications were recorded, and verbal analog pain scores (VAS) of all patients were calculated after surgical procedure.
Results: Postoperative hemorrhage rates were 17.5% in the first group and 6.6% in the second group. Hemorrhages in the first group were mostly reactionary, and only two of them required repacking. None of the patients in the second group required repacking. There was no statistically significant difference between the two groups depending on hemorrhage. First day mean VAS scores were similar in both groups. Second day mean VAS score of the second group was higher compared to first day VAS scores of both groups.
Conclusion: According to our study, routine use of 48-hour nasal packing after septoplasty is not necessary. We observed that prolonged nasal packing increases the postoperative pain significantly and has no significant beneficial effect on postoperative complications except in patients with hypertension.
Rhinology/Allergy Identification of Chronic Rhinosinusitis Phenotypes
Tsuguhisa Nakayama, MD (presenter); Daiya Asaka; Tetsushi Okushi; Hiroshi Moriyama, MD; Nobuyoshi Otori, MD; Mamoru Yoshikawa, MD, PhD; Yoshinori Matsuwaki, MD, PhD Objective: The pathogenesis of chronic rhinosinusitis is still unclear. A variety of factors are thought to be involved in the pathogenesis of chronic paranasal sinusitis. We sought to identify the phenotypes of chronic paranasal sinusitis patients by means of a cluster analysis.
Method:
We conducted a retrospective analysis of prospectively collected data from April 2007 to March 2008 in a multicenter study involving 5 hospitals.
Results:
The cluster analysis yielded 6 phenotypes: Cluster 1 (n = 102), low blood and tissue eosinophil counts; Cluster 2 (n = 118), slightly increased blood and tissue eosinophil counts, but higher CT polyp score than in Cluster 1; Cluster 3 (n = 84), moderately elevated IgE level and high blood eosinophil counts, but mild increase in tissue eosinophil counts, and common aspirin-tolerant asthma as comorbidity; Cluster 4 (n = 69), extremely high tissue eosinophil counts, but mild blood eosinophil increase; Cluster 5 (n = 20), hyperimmunoglobulinemia E and specific IgE antibodies to fungi and house dust mites; Cluster 6 (n = 6), all aspirin-intolerant.
Conclusion: Chronic rhinosinusitis was classified into 6 phenotypes according to the eosinophil, IgE, asthma, and nasal polyp findings. The pathogenesis of chronic paranasal sinusitis needs to be further investigated by including cases of recurrent disease.
Rhinology/Allergy
Immune Dysfunction in Chronic Rhinosinusitis C. W. David Chang, MD (presenter); Jason C. W. Goodwin, MD Objective: 1) Determine the prevalence of immunoglobulin abnormalities in patients with chronic rhinosinusitis. 2) Compare our results with similar studies for validity. 3) Draw conclusions on when to order these specific tests. 4) Alert providers on the prevalence and workup of immune deficiencies.
Method:
Retrospective study of all patients with CRS of a single provider, from 2008 to 2010, with attention given to those with refractory CRS on whom immunoglobulin laboratories were ordered. Measured variables were total patients, number of immune laboratories ordered, and results of those tests.
Results: At our institution, 334 patients were seen by a single provider with the diagnosis of CRS. Of these patients, immunoglobulin levels (IgG, IgG subclasses, IgM, IgA, and/or IgE) were ordered on 37 patients. Deficiencies of at least one immunoglobulin class were found on 20 patients (54 percent of patients tested). This demonstrates a 5.9% prevalence of immunoglobulin deficiency in our chronic sinusitis patient population. The most common deficiency noted on this study was an IgG subclass deficiency. Two patients demonstrated common variable immunoglobulinemia.
Conclusion: Despite aggressive medical and surgical therapy, CRS can be a persistent disease. Immunoglobulin deficiency is common in this subset of refractory patients. The clinician should be aware of this likelihood and order appropriate studies. Proper recognition can allow the clinician to tailor their management of these patients. Method: Case study of a patient with hereditary hemorrhagic telangiectasia detailing the clinical presentation and treatment algorithm of the disease. Comprehensive literature review detailing the pathophysiology and clinical presentation, with special attention to the surgical and advanced medical management of the disease.
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